March 27, 2019
Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/RSV?src=hash” target=”_blank”gt;#RSVlt;/agt;–Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced…